New Gene-Editing progress for Hepatitis B cure | PBGENE-HBV Shows Promising Results!

A groundbreaking *gene-editing therapy for chronic hepatitis B* is showing early success in clinical trials! Precision BioSciences’ investigational treatment, *PBGENE-HBV**, has demonstrated **antiviral activity and a promising safety profile* in its first group of patients.

In this video, we break down:
✔️ How PBGENE-HBV works to target and eliminate hepatitis B at its source
✔️ The latest findings from the *Phase 1 ELIMINATE-B clinical trial*
✔️ What this means for the future of *hepatitis B treatment*

Could this be the *functional cure* we've been waiting for? Stay updated on cutting-edge medical research by *subscribing to our channel* and turning on notifications!

🔔 *Subscribe now for more updates on medical breakthroughs!*
📢 *Share this video* to spread awareness about the latest advances in hepatitis B treatment.

#HepatitisB #GeneEditing #MedicalBreakthrough #PrecisionBioSciences #PBGENEHBV #ClinicalTrials #HepatitisBResearch #CureHepB #HealthInnovation #MedicalResearch